Reuters logo
BRIEF-Insurance unit of Hubei Biocause Pharma's premium income at 10.6 bln yuan in jan
February 13, 2017 / 7:44 AM / 7 months ago

BRIEF-Insurance unit of Hubei Biocause Pharma's premium income at 10.6 bln yuan in jan

Feb 13 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd

* Says insurance unit’s premium income at 10.6 billion yuan ($1.54 billion) in Jan

Source text in Chinese: bit.ly/2kisI2c

Further company coverage: ($1 = 6.8826 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below